Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Clinical Trials Going Active for Cellceutix Anti-Cancer Drug Kevetrin
Yahoo
Monday, October 8, 2012 - 10:43am
tags:
Cellceutix, Kevetrin, cancer
Regulus Therapeutics: Serious Red Flags At This Public Offering
Seeking Alpha
Monday, October 8, 2012 - 10:41am
tags:
Regulus, stock offering, Sanofi, GSK, AstraZeneca
What Is Going On With Sarepta Therapeutics?
Seeking Alpha
Monday, October 8, 2012 - 10:40am
tags:
Sarepta Therapeutics, Duchenne Muscular Dystrophy, eteplirsen
Scientists plan to detail research on potential Alzheimer's treatments from Eli Lilly, Pfizer
Yahoo/AP
Monday, October 8, 2012 - 10:38am
tags:
Eli Lilly, Alzheimer's disease, Pfizer, bapineuzumab, solanezumab
90% of Pharmaceutical Professionals See Positive Business Environment in Advance of CPhI Worldwide 2012 - the Leading Global Gathering of the Pharmaceutical Industry
Sacramento Bee, CA
Sunday, October 7, 2012 - 12:08pm
tags:
Huge Insider Buy Makes This $3.50 Biopharma Stock An Intriguing Speculative Play
Seeking Alpha
Sunday, October 7, 2012 - 12:06pm
tags:
Horizon Pharma
China Biotech In Review: Sanofi, Sinopharm To Conduct Joint Research Into Rare Diseases
Seeking Alpha
Sunday, October 7, 2012 - 12:05pm
tags:
Fosun Pharmaceutical, RuiYi, Sanofi, MediStem, China National Biotech Group, QPS Holdings
AstraZeneca’s New Strategy
Wall Street Cheat Street
Sunday, October 7, 2012 - 11:52am
tags:
AstraZeneca
What’s Next for Pfizer?
Wall Street Cheat Street
Sunday, October 7, 2012 - 11:52am
tags:
Pfizer
Generic antidepressant not equivalent to original Wellbutrin -FDA
Reuters
Sunday, October 7, 2012 - 11:51am
tags:
Wellbutrin, GSK, generics, Impax Laboratories, Teva Pharmaceuticals
Worth The Wait: Implications Of Cytori Therapeutics' $106 Million BARDA Contract
Seeking Alpha
Sunday, October 7, 2012 - 11:49am
tags:
Cytori
4 Under-The-Radar Systems In Biotechnology That Could Create Upside
Seeking Alpha
Sunday, October 7, 2012 - 11:48am
tags:
OncoSec Medical, Celsion, AngioDynamics, Accuray
Weekend Recap: Biotech Madness
Seeking Alpha
Sunday, October 7, 2012 - 11:47am
tags:
Sarepta Therapeutics, Synta Pharmaceuticals, Arena Pharmaceuticals, Arqule, Amarin, Acadia, Aeterna Zentaris
Did This High Dividend Stock Just Lower the Bar?
Motley Fool
Sunday, October 7, 2012 - 11:44am
tags:
PDL Biopharma
Why Does Billionaire Thomas Steyer’s Farallon Love This Pharmaceutical Company?
Motley Fool
Sunday, October 7, 2012 - 11:43am
tags:
Horizon Pharma
3 Biotech Stocks That Will Be Making Big Moves
Motley Fool
Sunday, October 7, 2012 - 11:42am
tags:
MannKind, Dendreon, Spectrum Pharmaceuticals
Vivus Announces Suit Dismissal and 4 Healthcare Stocks in Demand
Wall Street Cheat Street
Sunday, October 7, 2012 - 11:41am
tags:
Vivus, Arena Pharmaceuticals, Dendreon, Pfizer, Insmed
Healthcare Business Review: Watson Gets EU Approval, Stryker’s Bad News
Wall Street Cheat Street
Saturday, October 6, 2012 - 12:11pm
tags:
Watson, Actavis, M&A, Questcor, Acthar
Fosun set to tap HK stock market for US$600m
South China Morning Post
Saturday, October 6, 2012 - 12:09pm
tags:
Fosun Pharmaceutical
Pfizer to challenge Indian ruling overturning cancer drug patent
Economic Times, India
Saturday, October 6, 2012 - 12:06pm
tags:
Pfizer, Sutent

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.